Evidence map›Paper›PMID 35008409›Full record

ArticleCancers2022

Comparative

Chia-Hung Lin, Chen-Chung Liao, Shu-Ying Wang, Chia-Yi Peng, Yi-Chen Yeh, Mei-Yu Chen, Teh-Ying Chou

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Role of Sam68 in different types of cancer (Review).International journal of molecular medicine · 2025
    Review
  4. Review
  5. Review
  6. Role of Sam68 as an adaptor protein in inflammatory signaling.Cellular and molecular life sciences : CMLS · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chia-Hung LinDepartment of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei 11227, Taiwan.ORCID 0000-0002-1819-7310
Chen-Chung LiaoMetabolomics-Proteomics Research Center, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Shu-Ying WangInstitute of Clinical Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.
Chia-Yi PengInstitute of Biochemistry and Molecular Biology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.ORCID 0000-0002-4205-634X
Yi-Chen YehDepartment of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei 11227, Taiwan.
Mei-Yu ChenInstitute of Biochemistry and Molecular Biology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan.ORCID 0000-0002-5765-9178
Teh-Ying ChouDepartment of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei 11227, Taiwan.ORCID 0000-0001-5844-477X
National Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TW

Funding

the Ministry of Education, Taiwan the "Cancer Progression Research Center, National Yang Ming Chaio Tung University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Projectthe Ministry of Science and Technology, Taiwan MOST105-2320-B-075-003-MY3 and MOST108-2320-B-075-001-MY3
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

invasivenesslung adenocarcinomaO-GlcNAc transferaseO-GlcNAcylationSAM68

Identifiers

PMID35008409
PMCPMC8749979
OpenAlexW4206759196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.